$11.80 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Seer

Seer, Inc. is a life sciences technology company. The Company enables scientific outcomes by commercializing products for researchers to unlock biological information. Its initial product, the Proteograph Product Suite (Proteograph), uses its engineered nanoparticle (NP) technology to provide access across the proteome. Its Proteograph Product Suite is an integrated solution that is comprised of consumables, an automation instrument and software. Proteograph provides a workflow, which enables proteomic profiling and the analysis of samples needed to characterize the nature of the proteome. The Company's Proteograph consumables consist of its NP panel and other consumables necessary to assay samples on its automation instrument. Its Proteograph automation instrument is custom-configured liquid handling workstation. The Company's Proteograph Instrument Control Software (PICS) for the Proteograph is fixed and designed to its specified workflow.

Stock Analysis

last close $11.8
1-mo return 15.3%
3-mo return 35.6%
avg daily vol. 320.79T
52-week high 45.85
52-week low 6.44
market cap. $698M
forward pe -
annual div. -
roe -16.9%
ltg forecast -
dividend yield -
annual rev. $12M
inst own. 89%

Subscribe now for daily local and international financial news